Mechanistic insights into TNFR1/MADD death domains in Alzheimer's disease through conformational molecular dynamic
Mubashir Hassan1, Sara Zahid2, Hany Alashwal3
1Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. mubashirhassan_gcul@yahoo.com.
Abstract:
Proteins are tiny players involved in the activation and deactivation of multiple signaling cascades through interactions in cells. The TNFR1 and MADD interact with each other and mediate downstream protein signaling pathways which cause neuronal cell death and Alzheimer's disease. In the current study, a molecular docking approach was employed to explore the interactive behavior of TNFR1 and MADD proteins and their role in the activation of downstream signaling pathways. The computational sequential and structural conformational results revealed that Asp400, Arg58, Arg59 were common residues of TNFR1 and MADD which are involved in the activation of downstream signaling pathways. Aspartic acid in negatively charged residues is involved in the biosynthesis of protein. However, arginine is a positively charged residue with the potential to interact with oppositely charged amino acids. Furthermore, our molecular dynamic simulation results also ensured the stability of the backbone of TNFR1 and MADD death domains (DDs) in binding interactions. This DDs interaction mediates some conformational changes in TNFR1 which leads to the activation of mediators proteins in the cellular signaling pathways. Taken together, a better understanding of TNFR1 and MADD receptors and their activated signaling cascade may help treat Alzheimer's disease. The death domains of TNFR1 and MADD could be used as a novel pharmacological target for the treatment of Alzheimer's disease by inhibiting the MAPK pathway.
Insights
Researchers identified key interactions between TNFR1 and MADD proteins, revealing specific amino acid residues involved in neuronal cell death pathways relevant to Alzheimer's disease. Targeting these interactions offers a potential therapeutic strategy for Alzheimer's disease.
Area of Science:
- Molecular Biology
- Neuroscience
- Computational Biology
Background:
- Tumor Necrosis Factor Receptor 1 (TNFR1) and MADD proteins interact to mediate signaling pathways.
- These interactions are implicated in neuronal cell death and the pathogenesis of Alzheimer's disease.
Purpose of the Study:
- To investigate the interactive behavior of TNFR1 and MADD proteins using molecular docking.
- To explore their role in activating downstream signaling pathways linked to Alzheimer's disease.
Main Methods:
- Molecular docking simulations were used to analyze TNFR1-MADD protein interactions.
- Molecular dynamic simulations were performed to assess the stability of binding interactions between death domains.
Main Results:
- Identified common residues (Asp400, Arg58, Arg59) in TNFR1 and MADD crucial for activating downstream signaling.
- Confirmed the stability of TNFR1 and MADD death domains during binding interactions.
- Observed conformational changes in TNFR1 upon MADD interaction, activating mediator proteins.
Conclusions:
- Understanding TNFR1 and MADD interactions provides insights into Alzheimer's disease mechanisms.
- The death domains of TNFR1 and MADD represent a potential pharmacological target for Alzheimer's disease treatment.
- Inhibiting the MAPK pathway via targeting these death domains may offer a therapeutic avenue.
More Related Videos
10:19Single-Molecule FRET Imaging for Observing the Conformational Dynamics of Dynamin-Like GTPase Atlastin
Published on: January 24, 2025
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
